drugset / Trial / NCT06194201
A Trial of Intravenous HRS9432 in the Treatment of Subjects With Candidemia and/or Invasive Candidiasis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The Purpose of this study is to evaluate the efficacy and safety of intravenous HRS9432 in patients with candidemia and/or invasive candidiasis
Timeline
- Start
- 2024-04-27
- Primary completion
- 2026-06
- Completion
- 2026-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Caspofungin | Other / unclassified | 50 mg | Intravenous |
| Subject | HRS9432 | Unknown | — | Intravenous |